Last update 01 Nov 2024
Beijing Gorjest Technology Co., Ltd.

Beijing Gorjest Technology Co., Ltd.

Private Company|
2012|
Beijing Shi, China

Overview

Related

1
Drugs associated with Beijing Gorjest Technology Co., Ltd.
EndoTAG-1
Target
Tubulin
Mechanism
Tubulin inhibitors
Active Org.-
Originator Org.
SynCore Biotechnology Co., Ltd.SynCore Biotechnology Co., Ltd.
Active Indication-
Inactive Indication
Adenocarcinoma [+8]
Drug Highest PhaseSuspended
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Beijing Gorjest Technology Co., Ltd.
CTR20202537 / SuspendedPhase 3
EndoTAG-1联合吉西他滨与吉西他滨单药治疗可测量局部晚期和/或转移性胰腺癌有效性和安全性的多中心、随机、对照、开放、Ⅲ期临床研究
[Translation] A multicenter, randomized, controlled, open-label, phase III clinical study to measure the efficacy and safety of EndoTAG-1 combined with gemcitabine versus gemcitabine alone in the treatment of locally advanced and/or metastatic pancreatic cancer
100 Clinical Results associated with Beijing Gorjest Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Gorjest Technology Co., Ltd.
Login to view more data
100 Deals associated with Beijing Gorjest Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Gorjest Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
EndoTAG-1
 ( Tubulin )		Locally Advanced Pancreatic Adenocarcinoma
More
Suspended
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free